AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
FRUSEMIDE in Zimbabwe
1 product registered with MCAZ β 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LASINEX SOLUTION; INJECTION | 2025/12.5.1/7070 | ARAVAS PHARMACEUTICALS | active | 23 Sept 2030 |
FRUSEMIDE β MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing FRUSEMIDE, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track FRUSEMIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.